Abstract
摘要
相似文献
1
Meloxicam--a safer NSAID?
Drug Ther Bull. 1998 Aug;36(8):62-4.
2
[Meloxicam].
Rev Med Brux. 1998 Feb;19(1):29-32.
3
Meloxicam.
Expert Opin Pharmacother. 2002 Oct;3(10):1501-12. doi: 10.1517/14656566.3.10.1501.
4
Meloxicam: new formulations and their use in rheumatology.
Inflamm Res. 2001 Mar;50 Suppl 1:S3-4.
5
Relative safety of meloxicam in NSAID-intolerant patients.
Allergy. 1998 Dec;53(12):1231-3. doi: 10.1111/j.1398-9995.1998.tb03854.x.
6
Meloxicam (Mobic) for osteoarthritis.
Med Lett Drugs Ther. 2000 May 29;42(1079):47-8.
7
[Selective cyclooxygenase-2 inhibitor].
Internist (Berl). 1997 Oct;38(10):1007.
8
Meloxicam: selective COX-2 inhibition in clinical practice.
Semin Arthritis Rheum. 1997 Jun;26(6 Suppl 1):21-7. doi: 10.1016/s0049-0172(97)80049-2.
9
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
Br J Rheumatol. 1998 Sep;37(9):937-45. doi: 10.1093/rheumatology/37.9.937.
10
[Meloxicam--the balance of efficacy and safety].
Reumatizam. 2008;55(2):85-6.
Zotero 插件